Single doses of a highly selective inhibitor of phosphodiesterase 1 (lenrispodun) in healthy volunteers: a randomized pharmaco-fMRI clinical trial is a research paper published in Neuropsychopharmacology (2022). On theSindex it has a DataRank of 0.390. It has been cited 6 times, with 5 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.292
From this paper's citation signal
Citation Network Contribution
0.0981
From 4 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 5 citers.
NIDA NIH HHS
Grant: U01 DA041089
NIMH NIH HHS
Grant: K23 MH112949
NIGMS NIH HHS
Grant: P20 GM121312
National Institutes of Health
Grant: 5P20GM121312-03
The Center for Neuroscience-based Mental Health Assessment and Prediction (NEUROMAP)
National Institutes of Health
Grant: 5U01DA041089-05
ABCD-USA Consortium: Research Project
National Institutes of Health
Grant: 5K23MH112949-03
Neural Basis of Meal Related Interoceptive Dysfunction in Anorexia Nervosa
FWCI
0.62
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords